Stanozolol Oil Base

ACTIVE INGREDIENT

Each mL contains:

• Stanozolol 100 mg

DESCRIPTION

Stanozolol Oil Base 100 mg is an injectable anabolic steroid containing stanozolol, a synthetic derivative of dihydrotestosterone (DHT). It is suspended in an oil base to enhance absorption. Stanozolol has strong anabolic properties and mild androgenic effects, promoting muscle growth and protein synthesis without excessive water retention. It is commonly used in bodybuilding and for certain medical conditions like hereditary angioedema.

PHARMACOLOGICAL PROPERTIES

Mechanism of Action: Stanozolol acts by binding to androgen receptors, enhancing protein synthesis and nitrogen retention in muscles. It promotes muscle growth and can help increase strength and athletic performance. Due to its anabolic effects, it can also aid in preserving lean muscle mass.

Pharmacokinetics:

• Absorption: The oil-based formulation allows for a slower release of stanozolol compared to oral formulations, with a sustained effect after intramuscular administration.
• Distribution: Stanozolol is widely distributed in the body and binds to plasma proteins.
• Metabolism: Metabolized primarily in the liver.
• Excretion: Metabolites are excreted in the urine.

INDICATIONS

Stanozolol Oil Base 100 mg is indicated for:

Management of hereditary angioedema: To reduce the frequency and severity of attacks.

Treatment of anemia: To stimulate red blood cell production in certain cases.

Protein-sparing therapy: Used in conditions requiring the preservation of lean muscle mass.

Anabolic purposes: For muscle growth, strength enhancement, and performance improvement, particularly in those with catabolic states.

DOSAGE AND ADMINISTRATION

Dosage:

• Medical Use (e.g., hereditary angioedema): 2 mg/kg administered intramuscularly every 1–2 weeks. Dosage may vary depending on patient response and condition.
• Anabolic/Bodybuilding Use: Typical doses range from 50–100 mg administered intramuscularly every other day, although individual protocols vary based on goals and tolerance.

Administration: Administer intramuscularly. Deep injection into the gluteal or thigh muscle is preferred. Rotate injection sites regularly to minimize local irritation.

CONTRAINDICATIONS

• Hypersensitivity to stanozolol or any other ingredients in the formulation.

• Pregnancy or breastfeeding (Pregnancy Category X).

• Active or suspected breast cancer in women.

• Prostate cancer or suspicion of prostate malignancy.

• Severe liver, kidney, or cardiovascular disease.

• Hypercalcemia (increased calcium levels in the blood).

WARNINGS AND PRECAUTIONS

1. Hepatic Toxicity: Stanozolol is known for its potential to cause liver toxicity, particularly in high doses or with long-term use. Regular liver function tests are recommended.

2. Cardiovascular Risks: Prolonged use of anabolic steroids may increase the risk of cardiovascular issues such as atherosclerosis, hypertension, myocardial infarction, and stroke. Patients should be monitored for lipid profile changes and cardiovascular health.

3. Androgenic Effects: Stanozolol, while primarily anabolic, may cause androgenic effects like acne, hair loss, and increased body hair. Women may experience virilization (deepening of the voice, clitoral enlargement, menstrual irregularities).

4. Lipid Profile Alterations: Stanozolol can negatively affect cholesterol levels, decreasing HDL (good cholesterol) and increasing LDL (bad cholesterol). Regular lipid monitoring is advised.

5. Tendon Weakness: Stanozolol use has been associated with an increased risk of tendon damage. Caution is recommended during intense physical activity.

ADVERSE REACTIONS

Common adverse reactions:

• Dermatological effects: Acne, oily skin, hair loss (androgenic alopecia).
• Endocrine effects: Suppression of natural testosterone production, testicular atrophy.
• Musculoskeletal: Muscle cramps, tendon pain.
• Liver: Elevated liver enzymes, jaundice.

Serious adverse reactions:

• Hepatotoxicity: Liver damage, cholestatic hepatitis, hepatic tumors, and peliosis hepatis.
• Cardiovascular: Increased risk of blood clots, hypertension, and cardiovascular events.
• Endocrine: Gynecomastia (in males), virilization in women.
• Psychiatric effects: Aggression, mood swings, irritability, or depression.

INTERACTIONS

1. Anticoagulants: Stanozolol may enhance the effects of anticoagulants like warfarin, increasing the risk of bleeding. Close monitoring of INR is advised.

2. Insulin and Oral Antidiabetics: Anabolic steroids can affect blood sugar levels and may require adjustment of insulin or oral hypoglycemic medications.

3. Corticosteroids: Concurrent use with corticosteroids may exacerbate fluid retention and increase the risk of electrolyte imbalances.

USE IN SPECIFIC POPULATIONS

Pregnancy and Lactation: Stanozolol is contraindicated in pregnancy due to the risk of fetal harm (Pregnancy Category X). It should not be used during breastfeeding.

Pediatric Use: Caution should be exercised when administering stanozolol to pediatric patients, as it may cause premature closure of growth plates (epiphyseal closure) and stunt growth.

Geriatric Use: Geriatric patients may be more susceptible to the cardiovascular and hepatic effects of stanozolol. Monitoring is required during use in this population.

OVERDOSAGE

There is no specific antidote for stanozolol overdose. In the case of overdose, discontinue use and provide symptomatic treatment. Liver and cardiovascular function should be monitored closely.

STORAGE

Store below 25°C (77°F). Protect from light. Do not refrigerate or freeze. Keep out of reach of children.

PACKAGING

Stanozolol Oil Base 100 mg is supplied in 10 mL vials, each containing 100 mg of stanozolol in an oil-based solution.

MANUFACTURER

Oxydine Metabolics Switzerland

Oxydine.org
Hi@Oxydine.org